Replies to post #11175 on Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

In September 2007, our board of directors, upon recommendation of the compensation committee, approved a stock ownership and
retention program for our executive officers and directors. The purpose of the program is to ensure that each of our executive officers and directors has a long-term equity stake in Momenta, to more closely align the interests of the executive officers and directors with those of our stockholders and to further promote our commitment to sound corporate governance.


As of March 31, 2013, we had two directors and one executive officer that did not hold stock sufficient to satisfy the stock ownership requirements. The compensation committee reviewed the holdings of each of the individuals and concluded to take no other action than the restrictions outlined in the Stock Ownership Guidelines, as had been amended in December 2012, namely that each such director and executive officer is required to retain shares of restricted stock upon the lapse of vesting restrictions, net of shares surrendered or sold to pay applicable withholding taxes and each such director and executive officer may not exercise and sell any stock options (other than to sell or surrender shares for payment of any taxes related to stock option exercises), including without limitation any sales pursuant to a 10b5-1 plan until such time as such director or executive officer is in compliance with the Stock Ownership Guidelines.

[DewDiligence]

MNTA Insider Shareholdings

[Updated for Form-4 filings through 3/5/14, including
the awards of options and restricted stock on 2/18/14 (http://www.sec.gov/Archives/edgar/data/1235010/000110465914015828/a14-7329_18ka.htm ). ]

The table entries below include both ordinary and restricted
shares and both vested and non-vested options.

 
                              Shares    Options 
 Officers 
 *Craig Wheeler (CEO)        631,645  1,192,000 
 *G Venkataraman (SVP/R&D)   363,892    268,378 
 *John Bishop (SVP/Pharma)   111,069    185,946 
 *Richard Shea (CFO)         179,447    346,153 
 *Bruce Leicher (Gen Cnsl)   128,270    258,732 
 *James Roach (CMO)          105,022    310,915 
 ‡Michael Franken (FoB Pres.) 25,000          0 
  
 Directors 
 John Clarke                  69,123    179,250 
 Bruce Downey                      0     98,250 
 Marsha Fanucci                9,000    140,850 
 Peter Hutt                    5,365    184,250 
 Thomas Koestler                   0     65,500 
 *Bennett Shapiro              7,000    158,450 
 *Elizabeth Stoner            11,143    104,117 
 James Sulat                  10,000    103,250 
 ========================= =========  ========= 
 All fifteen insiders      1,655,976  3,596,041

*10b5-1 selling plan in effect.

‡Hired 12/12/13.